AORT
Artivion Inc

317
Mkt Cap
$1.93B
Volume
126,882.00
52W High
$48.25
52W Low
$21.97
PE Ratio
-163.60
AORT Fundamentals
Price
$39.77
Prev Close
$39.59
Open
$39.26
50D MA
$44.27
Beta
0.98
Avg. Volume
302,329.85
EPS (Annual)
-$0.32
P/B
4.28
Rev/Employee
$242,835.63
$1,500.31
Loading...
Loading...
News
all
press releases
Artivion, Inc. (NYSE:AORT) Given Average Recommendation of "Moderate Buy" by Brokerages
Artivion, Inc. (NYSE:AORT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the nine brokerages that are presently covering the stock, Marketbeat reports. One analyst...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Artivion (AORT) to Release Earnings on Thursday
Artivion (NYSE:AORT) will be releasing its Q4 2025 earnings after the market closes on Thursday, February 12. (View Earnings Report at...
MarketBeat·4d ago
News Placeholder
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025...
PR Newswire·11d ago
News Placeholder
Relative Strength Alert For Artivion
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·26d ago
News Placeholder
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks linger.
Zacks·1mo ago
News Placeholder
RBOT Enters Strategic Software Partnership to Streamline Development
Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.
Zacks·1mo ago
News Placeholder
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?
Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation patients.
Zacks·2mo ago
News Placeholder
Squarepoint Ops LLC Takes $664,000 Position in Artivion, Inc. $AORT
Squarepoint Ops LLC bought a new position in Artivion, Inc. (NYSE:AORT - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought...
MarketBeat·2mo ago
News Placeholder
Wall Street Zen Upgrades Artivion (NYSE:AORT) to Strong-Buy
Wall Street Zen raised Artivion from a "buy" rating to a "strong-buy" rating in a research note on Sunday...
MarketBeat·2mo ago
<
1
2
...
>

Latest AORT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.